1. Optimizing Surrogate End Points for Preoperative Systemic Therapies in Non-Small Cell Lung Cancers

   • William N. William Jr.
   • Stephen G. Swisher

   Thoracic Oncology 16 May 2014 Pages: 2813 - 2814

2. Three Angels are Dancing on the Head of the Esophageal Cancer Pin, but Shouldn’t We Not Topple One or Two?

   • Jaffer A. Ajani
   • Stephen G. Swisher

   Thoracic Oncology 23 April 2014 Pages: 2815 - 2816

3. More Harm than Good?

   • Jennifer L. Gnerlich
   • Mitchell C. Posner

   Pancreatic Tumors 15 July 2014 Pages: 2817 - 2819

4. Breast Cancer Biology: Implications for Local-Regional Therapy

   • Elizabeth A. Mittendorf
   • Isabelle Bedrosian

   Breast Oncology 22 April 2014 Pages: 2820 - 2822

5. Cost of Contralateral Prophylactic Mastectomy

   • Ashish A. Deshmukh
   • Scott B. Cantor
   • Abenaa M. Brewster

   Healthcare Policy and Outcomes 09 May 2014 Pages: 2823 - 2830

   

6. ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography versus Computed Tomography in Predicting Histopathological Response to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor Treatment in Resectable Non-Small Cell Lung Cancer

   • Matthijs H. van Gool
   • Tjeerd S. Aukema
   • Houke M. Klomp

   Thoracic Oncology 21 May 2014 Pages: 2831 - 2837

   

7. Outcomes of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Esophagectomy in Patients with Resectable Node-Positive Esophageal Cancer

   • Masayuki Watanabe
   • Yoshifumi Baba
   • Hideo Baba

   Thoracic Oncology 09 April 2014 Pages: 2838 - 2844

   

8. The Usefulness of Neoadjuvant Chemoradiation Therapy for Locally Advanced Esophageal Cancer with Multiple Lymph-Node Metastases

   • Hiroshi Okumura
   • Yasuto Uchikado
   • Shoji Natsugoe

   Gastrointestinal Oncology 14 April 2014 Pages: 2845 - 2849

   

9. Evaluation of the Nodal Status in the 7th Edition of the UICC-TNM Classification for Esophageal Squamous Cell Carcinoma: Proposed Modifications for Improved Survival Stratification

   • Makoto Yamasaki
   • Hiroshi Miyata
   • Yuichiro Doki

   Thoracic Oncology 14 April 2014 Pages: 2850 - 2856

   

10. Number of Negative Lymph Nodes is Associated with Survival in Thoracic Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy

    • Zhengfei Zhu
    • Haiquan Chen
    • Kuaile Zhao

    Thoracic Oncology 18 April 2014 Pages: 2857 - 2863

    

11. Optimal Approach to Circumferential Decompression and Reconstruction for Thoracic Spine Metastatic Disease

    • Neil R. Malhotra
    • Jennifer Kosty
    • Sherman C. Stein

    Thoracic Oncology 14 April 2014 Pages: 2864 - 2872

    

12. The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma

    • Wenchuan Wu
    • Jin He
    • Matthew J. Weiss

    Pancreatic Tumors 26 April 2014 Pages: 2873 - 2881

    

13. Basing Treatment Strategy for Non-functional Pancreatic Neuroendocrine Tumors on Tumor Size

    • Yoji Kishi
    • Kazuaki Shimada
    • Tomoo Kosuge

    Pancreatic Tumors 18 April 2014 Pages: 2882 - 2888

    

14. Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

    • Elizabeth L. Cureton
    • Christina Yau
    • Laura J. Esserman

    Breast Oncology 01 May 2014 Pages: 2889 - 2896

    

15. The Extent of Extracapsular Extension May Influence the Need for Axillary Lymph Node Dissection in Patients with T1–T2 Breast Cancer

    • Jessica Gooch
    • Tari A. King
    • Monica Morrow

    Breast Oncology 29 April 2014 Pages: 2897 - 2903

    

16. Axillary Ultrasonography in Breast Cancer Patients Helps in Identifying Patients Preoperatively with Limited Disease of the Axilla

    • A. M. Moorman
    • R. L. J. H. Bourez
    • E. A. Kouwenhoven

    Breast Oncology 09 April 2014 Pages: 2904 - 2910

17. The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy

    • Salma Butt
    • Talha Butt
    • Signe Borgquist

    Breast Oncology 29 April 2014 Pages: 2911 - 2919

    

18. Impact of Bilateral Versus Unilateral Mastectomy on Short Term Outcomes and Adjuvant Therapy, 2003–2010: A Report from the National Cancer Data Base

    • Susan M. Sharpe
    • Erik Liederbach
    • Katharine Yao

    Breast Oncology 12 April 2014 Pages: 2920 - 2927

    

19. A Novel Morphologic-Molecular Recurrence Predictive Model Refines Traditional Prognostic Tools for Invasive Breast Carcinoma

    • Yun-Bi Ni
    • Julia Y. S. Tsang
    • Gary M. Tse

    Breast Oncology 18 April 2014 Pages: 2928 - 2933

    

20. Impact of Breast Reconstruction on the Decision to Undergo Contralateral Prophylactic Mastectomy

    • Awais Ashfaq
    • Lee J. McGhan
    • Nabil Wasif

    Breast Oncology 23 April 2014 Pages: 2934 - 2940

    

21. Open Versus Minimally Invasive Resection of Gastric GIST: A Multi-Institutional Analysis of Short- and Long-Term Outcomes

    • Danielle A. Bischof
    • Yuhree Kim
    • Timothy M. Pawlik

    Bone and Soft Tissue Sarcomas 24 April 2014 Pages: 2941 - 2948

    

22. Prognostic Impact of Primary Tumor Resection and Lymph Node Dissection in Stage IV Colorectal Cancer with Unresectable Metastasis: A Propensity Score Analysis in a Multicenter Retrospective Study

    • Soichiro Ishihara
    • Tamuro Hayama
    • Toshiaki Watanabe

    Colorectal Cancer 24 April 2014 Pages: 2949 - 2955

23. A Retrospective Review of 126 High-Grade Neuroendocrine Carcinomas of the Colon and Rectum

    • James D. Smith
    • Diane L. Reidy
    • Garrett M. Nash

    Colorectal Cancer 24 April 2014 Pages: 2956 - 2962

    

24. Insight into Mucinous Colorectal Carcinoma: Clues from Etiology

    • Niek Hugen
    • Jasper J. P. van Beek
    • Iris D. Nagtegaal

    Colorectal Cancer 12 April 2014 Pages: 2963 - 2970

    

25. Pancreastatin Predicts Survival in Neuroendocrine Tumors

    • Scott K. Sherman
    • Jessica E. Maxwell
    • James R. Howe

    Endocrine Tumors 22 April 2014 Pages: 2971 - 2980

    

26. Does Completion Thyroidectomy Improve the Outcome of Patients with Minimally Invasive Follicular Carcinoma of the Thyroid?

    • Kiminori Sugino
    • Kaori Kameyama
    • Koichi Ito

    Endocrine Tumors 26 April 2014 Pages: 2981 - 2986

    

27. Suitability of Sentinel Node Mapping as an Index of Metastasis in Early Gastric Cancer Following Endoscopic Resection

    • Shuhei Mayanagi
    • Hiroya Takeuchi
    • Yuko Kitagawa

    Gastrointestinal Oncology 31 March 2014 Pages: 2987 - 2993

    

28. Risk Factors and Learning Curve Associated with Postoperative Morbidity of Laparoscopic Total Gastrectomy for Gastric Carcinoma

    • Oh Jeong
    • Seong Yeop Ryu
    • Young Kyu Park

    Gastrointestinal Oncology 01 April 2014 Pages: 2994 - 3001

    

29. Diagnostic Value of Computed Tomography for Staging of Clinical T1 Gastric Cancer

    • H. Fujikawa
    • T. Yoshikawa
    • M. Masuda

    Gastrointestinal Oncology 01 April 2014 Pages: 3002 - 3007

    

30. Morbidity and Mortality Associated with Gastrectomy for Gastric Cancer

    • Wesley A. Papenfuss
    • Moshim Kukar
    • Neal W. Wilkinson

    Gastrointestinal Oncology 04 April 2014 Pages: 3008 - 3014

31. Low Creatinine Clearance is a Risk Factor for D2 Gastrectomy after Neoadjuvant Chemotherapy

    • Tsutomu Hayashi
    • Toru Aoyama
    • Takaki Yoshikawa

    Gastrointestinal Oncology 09 April 2014 Pages: 3015 - 3022

32. Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis

    • Wim Ceelen
    • Yves Van Nieuwenhove
    • Piet Pattyn

    Gastrointestinal Oncology 23 April 2014 Pages: 3023 - 3028

    

33. Laparoscopic Total Colectomy with Transvaginal Extraction of the Colon and Ileorectal Anastomosis

    • Ziad Awad

    Original Article – Gastrointestinal Oncology 18 April 2014 Pages: 3029 - 3029

34. Laparotomy Conversion Rate of Laparoscopic Radical Hysterectomy for Early-stage Cervical Cancer in a Consecutive Series without Case Selection

    • Jeong-Yeol Park
    • Joo-Hyun Nam

    Gynecologic Oncology 21 April 2014 Pages: 3030 - 3035

    

35. Dualistic Classification of Epithelial Ovarian Cancer: Surgical and Survival Outcomes in a Large Retrospective Series

    • Pierluigi Benedetti Panici
    • Claudia Marchetti
    • Ludovico Muzii

    Gynecologic Oncology 28 April 2014 Pages: 3036 - 3041

    

36. Treatment of the Neck in Carcinoma of the Parotid Gland

    • Safina Ali
    • Frank L. Palmer
    • Ian Ganly

    Head and Neck Oncology 10 April 2014 Pages: 3042 - 3048

    

37. Minimum Nodal Yield in Oral Squamous Cell Carcinoma: Defining the Standard of Care in a Multicenter International Pooled Validation Study

    • Ardalan Ebrahimi
    • Jonathan R. Clark
    • Ziv Gil

    Head and Neck Oncology 14 April 2014 Pages: 3049 - 3055

    

38. Outcome of Patients Undergoing Salvage Surgery for Recurrent Nasopharyngeal Carcinoma: A Meta-analysis

    • Shorook Na’ara
    • Moran Amit
    • Ziv Gil

    Head and Neck Oncology 18 April 2014 Pages: 3056 - 3062

    

39. Effect of Body Composition on Outcomes after Hepatic Resection for Hepatocellular Carcinoma

    • Shinji Itoh
    • Ken Shirabe
    • Yoshihiko Maehara

    Hepatobiliary Tumors 10 April 2014 Pages: 3063 - 3068

    

40. Comparison of Survival of Patients with BCLC Stage A Hepatocellular Carcinoma After Hepatic Resection or Transarterial Chemoembolization: A Propensity Score-Based Analysis

    • Zhe Guo
    • Jian-Hong Zhong
    • Le-Qun Li

    Hepatobiliary Tumors 12 April 2014 Pages: 3069 - 3076

    

41. Colorectal Liver Metastases Growth in the Embolized and Non-Embolized Liver After Portal Vein Embolization: Influence of Initial Response to Induction Chemotherapy

    • Romain Pommier
    • Maxime Ronot
    • Valérie Vilgrain

    Hepatobiliary Tumors 18 April 2014 Pages: 3077 - 3083

42. γ-Glutamyltranspeptidase is a Prognostic Marker of Survival and Recurrence in Radiofrequency-Ablation Treatment of Hepatocellular Carcinoma

    • Hui Ma
    • Lan Zhang
    • Zhenggang Ren

    Hepatobiliary Tumors 21 April 2014 Pages: 3084 - 3089

    

43. Radiofrequency Ablation of Hepatic Metastases: Factors Influencing Local Tumor Progression

    • Chang-Hsien Liu
    • Chih-Yung Yu
    • Yu-Ching Chou

    Hepatobiliary Tumors 01 May 2014 Pages: 3090 - 3095

    

44. Is Resection or Transplantation the ideal Treatment in Patients with Hepatocellular Carcinoma in Cirrhosis if Both Are Possible? A Systematic Review and Metaanalysis

    • Andrea Proneth
    • Florian Zeman
    • Andreas A. Schnitzbauer

    Hepatobiliary Tumors 28 May 2014 Pages: 3096 - 3107

    

45. Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease

    • Augustinus P. T. van der Ploeg
    • Lauren E. Haydu
    • John F. Thompson

    Melanomas 07 May 2014 Pages: 3108 - 3116

    

46. Observation After a Positive Sentinel Lymph Node Biopsy in Patients with Melanoma

    • Zubin M. Bamboat
    • Ioannis T. Konstantinidis
    • Daniel G. Coit

    Melanomas 16 May 2014 Pages: 3117 - 3123

    

47. Innovative Rapid Gene Methylation Analysis of Surgical Margin Tissues in Head and Neck Cancer

    • Masamichi Hayashi
    • Rafael Guerrero-Preston
    • Wayne Koch

    Translational Research and Biomarkers 27 March 2014 Pages: 3124 - 3131

    

48. External Validation of Online Predictive Models for Prediction of Cancer-specific Mortality and All-cause Mortality in Patients with Urothelial Carcinoma of the Urinary Bladder

    • Kyung Chul Moon
    • Myong Kim
    • Ja Hyeon Ku

    Urologic Oncology 04 March 2014 Pages: 3132 - 3141

    

49. Prognostic Value of Diametrically Polarized Tumor-Associated Macrophages in Renal Cell Carcinoma

    • Le Xu
    • Yu Zhu
    • Jiejie Xu

    Urologic Oncology 11 March 2014 Pages: 3142 - 3150

    

50. Independent Predictors for Bladder Outcomes after Treatment of Intravesical Recurrence following Radical Nephroureterectomy in Patients with Primary Upper Tract Urothelial Carcinoma

    • Nobuyuki Tanaka
    • Eiji Kikuchi
    • Mototsugu Oya

    Urologic Oncology 29 March 2014 Pages: 3151 - 3158